Patients with CML in the lymphoid blastic phase have inferior response to anti-CD19 CAR T-cell therapy compared to de novo Ph-positive B cell acute lymphoblastic leukemia

被引：0

作者：

Liu, Mei-Jing ^{[1
,2
]}

Tan, Kai-Wen ^{[1
,2
]}

Cao, Han-Yu ^{[1
,2
]}

Huang, Si-Man ^{[1
,2
]}

Qian, Chong-Sheng ^{[1
,2
]}

Xue, Sheng-Li ^{[1
,2
]}

Dai, Hai-Ping ^{[1
,2
]}

Gong, Wen-Jie ^{[1
,2
]}

机构：

[1] First Affiliated Hosp Soochow Univ, Jiangsu Inst Hematol, Natl Clin Res Ctr Hematol Dis, Suzhou 215006, Peoples R China

[2] Soochow Univ, Inst Blood & Marrow Transplantat, Collaborat Innovat Ctr Hematol, Suzhou, Peoples R China

来源：

HEMASPHERE | 2024年 / 8卷 / 02期

关键词：

FOLLOW-UP; DASATINIB; EFFICACY;

D O I：

10.1002/hem3.49

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：4

共 50 条

[1] Anti-CD19 chimeric antigen receptor T-cell therapy for B-cell acute lymphoid leukemia
Rapoport, Aaron P.
REVISTA CHILENA DE LITERATURA, 2024, (109): : 1019 - 1020
[2] Anti-CD19 chimeric antigen receptor T-cell therapy for B-cell acute lymphoid leukemia
Rapoport, Aaron P.
HAEMATOLOGICA, 2024, 109 (04) : 1019 - 1020
[3] Anti-CD19 CAR T-cell consolidation therapy combined with CD19+feeding T cells and TKI for Ph plus acute lymphoblastic leukemia
Chen, Li-Yun
Gong, Wen-Jie
Li, Ming-Hao
Zhou, Hai-Xia
Xu, Ming-Zhu
Qian, Chong-Sheng
Kang, Li-Qing
Xu, Nan
Yu, Zhou
Qiao, Man
Zhang, Tong-Tong
Zhang, Ling
Tian, Zheng-Long
Sun, Ai-Ning
Yu, Lei
Wu, De-Pei
Xue, Sheng-Li
BLOOD ADVANCES, 2023, 7 (17) : 4913 - 4925
[4] Efficacy and safety of anti-CD19 CAR T-cell therapy in 110 patients with B-cell acute lymphoblastic leukemia with high-risk features
Zhang, Xian
Lu, Xin-an
Yang, Junfang
Zhang, Gailing
Li, Jingjing
Song, Lisong
Su, Yunchao
Shi, Yanze
Zhang, Min
He, Jiujiang
Song, Dan
Lv, Fanyong
Li, Wenqian
Wu, Yan
Wang, Hui
Liu, Hongxing
Zhou, Xiaosu
He, Ting
Lu, Peihua
BLOOD ADVANCES, 2020, 4 (10) : 2325 - 2338
[5] Treatment of CML-transformed B Cell Acute Lymphoblastic Leukemia (B-ALL) in Adults with Anti-CD19 Chimeric Antigen Receptor T Cell (CAR T) Therapy
Fang Liu
Sha Sha
Gina Ma
Yi Su
Yisong Xiong
Guangcui He
Yecheng Li
William M. Hanes
William Tse
Stem Cell Reviews and Reports, 2020, 16 : 1356 - 1358
[6] Treatment of CML-transformed B Cell Acute Lymphoblastic Leukemia (B-ALL) in Adults with Anti-CD19 Chimeric Antigen Receptor T Cell (CAR T) Therapy
Liu, Fang
Sha, Sha
Ma, Gina
Su, Yi
Xiong, Yisong
He, Guangcui
Li, Yecheng
Hanes, William M.
Tse, William
STEM CELL REVIEWS AND REPORTS, 2020, 16 (06) : 1356 - 1358
[7] Anti-CD19 CAR T-cell therapy post antibody treatment in adult patients with relapsed/refractory precursor B-acute lymphoblastic leukemia
Danylesko, Ivetta
Besser, Michal
Jacoby, Elad
Itzhaki, Orit
Shem-Tov, Noga
Yerushalmi, Ronit
Toren, Amos
Shimoni, Avichai
Nagler, Arnon
Avigdor, Abraham
BONE MARROW TRANSPLANTATION, 2019, 54 : 517 - 518
[8] Impact of tocilizumab on anti-CD19 chimeric antigen receptor T-cell therapy in B-cell acute lymphoblastic leukemia
Wang, Xiangmin
Zhang, Bingpei
Zhang, Qing
Zhou, Hongyuan
Sun, Qian
Zhou, Yi
Li, Tianci
Zhou, Dian
Shen, Ziyuan
Zhang, Jiaoli
Li, Ping
Liang, Aibin
Zhou, Keshu
Han, Lu
Hu, Yongxian
Yang, Yun
Cao, Jiang
Li, Zhenyu
Xu, Kailin
Sang, Wei
CANCER, 2024, 130 (15) : 2660 - 2669
[9] Pharmacodynamic Profile and Clinical Response in Patients with B-Cell Malignancies of Anti-CD19 CAR T-Cell Therapy
Perez, Arianne
Navale, Lynn
Rossi, John M.
Shen, Yueh-wei
Jiang, Yizhou
Sherman, Marika
Mardiros, Armen
Yoder, Sean C.
Go, William Y.
Rosenberg, Steven A.
Wiezorek, Jeff
Roberts, Margo R.
Chang, David D.
Kochenderfer, James N.
Bot, Adrian
BLOOD, 2015, 126 (23)
[10] High Response Rates Following Point-of-Care Anti-CD19 CAR T-Cell Therapy in Adults with Relapsed/Refractory Acute B Lymphoblastic Leukemia
Fried, Shalev
Danylesko, Ivetta
Marcus, Ronit
Itzhaki, Orit
Yerushalmi, Ronit
Shem-Tov, Noga
Sdayoor, Inbal
Shouval, Roni
Jacoby, Elad
Kedmi, Meirav
Nagler, Arnon
Shimoni, Avichai
Avigdor, Abraham
BLOOD, 2023, 142

← 1 2 3 4 5 →